Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Antiandrogens don't help with COVID-19 and aren't recommended.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Cortisol and corticosterone thin mouse skin and regress hair follicles, while testosterone promotes skin and hair development.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Cyclosporin and minoxidil promote hair growth.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Steroid pulse therapy improved symptoms in a man with Satoyoshi syndrome.

Possible link between androgens and COVID-19 severity; more research needed.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.